SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001628280-24-038073
Filing Date
2024-08-21
Accepted
2024-08-21 18:27:03
Documents
3
Period of Report
2024-08-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 wk-form3_1724279217.html 3  
1 FORM 3 wk-form3_1724279217.xml 3 2213
2 EX-24 poa_mkorenberg.htm EX-24 3528
3 poa_mkorenberg001.jpg GRAPHIC 243302
  Complete submission text file 0001628280-24-038073.txt   342449
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Issuer) CIK: 0001005286 (see all company filings)

IRS No.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 11119 NORTH TORREY PINES ROAD SUITE 200 LA JOLLA CA 92037
Business Address
Korenberg Matthew E (Reporting) CIK: 0001649903 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-27446 | Film No.: 241229690